Sensei Biotherapeutics Company
Sensei Biotherapeutics is a clinical-stage biotechnology company specializing in the field of next-generation cancer immunotherapies.
Employee Number:
1-10
Estimated Revenue:
$1M to $10M
Funding Status:
IPO
Industry:
PharmTech
Technology:
Small Molecules
Headquarters:
Gaithersburg, Maryland, United States